로딩 중…
지수 로딩 중…
CRISPR Therapeutics AG
CRSP· NASDAQ· Health Care· Pharmaceuticals, Biotechnology & Life Sciences
CH
CH$54.09+1.88%
2026-06-18
Price Chart
CRISPR Therapeutics AG+21.74%
Financials
※ FY = Fiscal Year
Investment Metrics(as of 2026-06-18)
| Metric | Value |
|---|---|
| Size | |
| Market Cap | $5.22B |
| Revenue | $4M |
| Net Income | $-569M |
| Total Assets | $2.73B |
| Net Assets | $1.81B |
| Value | |
| P/B | 2.88x |
| FCF Yield | -7.69% |
| Profitability | |
| ROE | -31.33% |
| ROA | -20.86% |
| Op. Margin | -13408.29% |
| Revenue Growth | 68.55% |
| Financial Health | |
| Debt Ratio | 50.22% |
| Total Debt | $788M |
| FCF | $-401M |
| Cash | $423M |
| Current Ratio | 17.96x |
| Performance | |
| 1Y Return | 21.74% |
| 1M Return | 13.66% |
| From 52W High | -31.08% |
| 1Y MDD | -42.25% |
| Trading | |
| Volume | 1,777,984 shares |
| Trading Value | $97M |
| Per Share | |
| EPS | $-6.47 |
| BPS | $21.37 |